Department of Natural Science, School of Science and Technology, Middlesex University, London, United Kingdom.
School of Medicine, Griffith University, Gold Coast, Queensland, Australia.
PLoS One. 2021 Mar 17;16(3):e0248723. doi: 10.1371/journal.pone.0248723. eCollection 2021.
In Iran, trends in breast cancer incidence and mortality have generally been monitored at national level. The purpose of this study is to examine province-level disparities in age-standardised breast cancer incidence versus mortality from 2000 to 2010 and their association with socioeconomic status.
In this study, data from Iran's national cancer and death registry systems, and covariates from census and household expenditure surveys were used. We estimated the age-standardised incidence and mortality rates in women aged more than 30 years for all 31 provinces in the consecutive time intervals 2000-2003, 2004-2007 and 2008-2010 using a Bayesian spatial model.
Mean age-standardised breast cancer incidence across provinces increased over time from 15.0 per 100,000 people (95% credible interval 12.0,18.3) in 2000-2003 to 39.6 (34.5,45.1) in 2008-2010. The mean breast cancer mortality rate declined from 10.9 (8.3,13.8) to 9.9 (7.5,12.5) deaths per 100,000 people in the same period. When grouped by wealth index quintiles, provinces in the highest quintile had higher levels of incidence and mortality. In the wealthiest quintile, reductions in mortality over time were larger than those observed among provinces in the poorest quintile. Relative breast cancer mortality decreased by 16.7% in the highest quintile compared to 10.8% in the lowest quintile.
Breast cancer incidence has increased over time, with lower incidence in the poorest provinces likely driven by underdiagnoses or late-stage diagnosis. Although the reported mortality rate is still higher in wealthier provinces, the larger decline over time in these provinces indicates a possible future reversal, with the most deprived provinces having higher mortality rates. Ongoing analysis of incidence and mortality at sub-national level is crucial in addressing inequalities in healthcare systems and public health both in Iran and elsewhere.
在伊朗,乳腺癌发病率和死亡率的趋势通常在国家层面进行监测。本研究旨在研究 2000 年至 2010 年期间按年龄标准化的乳腺癌发病率与死亡率的省级差异及其与社会经济地位的关系。
本研究使用了伊朗国家癌症和死亡登记系统的数据,以及人口普查和家庭支出调查的协变量。我们使用贝叶斯空间模型,对 31 个省份 30 岁以上女性的年龄标准化发病率和死亡率进行了估计,时间间隔为 2000-2003 年、2004-2007 年和 2008-2010 年。
各省份的平均年龄标准化乳腺癌发病率随时间推移而增加,从 2000-2003 年的 15.0/100,000 人(95%可信区间 12.0,18.3)增加到 2008-2010 年的 39.6(34.5,45.1)。同期,乳腺癌死亡率从 10.9(8.3,13.8)降至 9.9(7.5,12.5)人/100,000 人。按照财富指数五分位数分组,财富最高五分位数的省份发病率和死亡率较高。在最富有的五分位数中,死亡率随时间的下降幅度大于最贫穷五分位数的死亡率下降幅度。与最低五分位数相比,最高五分位数的相对乳腺癌死亡率下降了 16.7%,而最低五分位数则下降了 10.8%。
乳腺癌发病率随时间推移而增加,最贫困省份的发病率较低,可能是由于漏诊或晚期诊断。尽管报告的死亡率在较富裕的省份仍然较高,但这些省份死亡率随时间的较大下降表明,未来可能会出现逆转,最贫困的省份死亡率较高。在伊朗和其他地方,对国家以下一级发病率和死亡率的持续分析对于解决医疗保健系统和公共卫生方面的不平等至关重要。